NCT01935882View on ClinicalTrials.gov

Low Dose Primaquine for Clearance of Gametocytes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
MalariaAsymptomatic MalariaPlasmodium Falciparum
Interventions
DRUG

Artemether-lumefantrine combination

DRUG

Artemether-Lumefantrine with a single dose of 0.25mg/kg primaquine

DRUG

Artemether-Lumefantrine with a single dose of 0.4mg/kg primaquine

Trial Locations (1)

Unknown

Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

Centre national de recherche et de formation sur le paludisme

OTHER_GOV

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01935882 - Low Dose Primaquine for Clearance of Gametocytes | Biotech Hunter | Biotech Hunter